予防可能型ワクチンの世界市場（～2026年）

• 英文タイトル：Global Preventable Vaccines Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY14356 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、180ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は予防可能型ワクチンのグローバル市場について調査・分析したレポートです。種類別（成人用予防可能型ワクチン、小児用予防可能型ワクチン）市場規模、用途別（細菌性疾患、ウイルス性疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別予防可能型ワクチンの競争状況、市場シェア ・世界の予防可能型ワクチン市場：種類別市場規模 2015年-2020年（成人用予防可能型ワクチン、小児用予防可能型ワクチン） ・世界の予防可能型ワクチン市場：種類別市場規模予測 2021年-2026年（成人用予防可能型ワクチン、小児用予防可能型ワクチン） ・世界の予防可能型ワクチン市場：用途別市場規模 2015年-2020年（細菌性疾患、ウイルス性疾患） ・世界の予防可能型ワクチン市場：用途別市場規模予測 2021年-2026年（細菌性疾患、ウイルス性疾患） ・北米の予防可能型ワクチン市場分析：米国、カナダ ・ヨーロッパの予防可能型ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの予防可能型ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の予防可能型ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの予防可能型ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Merck、Novartis、Pfizer、Sanofi、Takeda Pharmaceutical、Abbott、Roche、AstraZeneca、Mitsubishi Tanabe Pharma、Lupin、Serum Institute of India、LG Life Sciences、S K Chemicals、Shenzhen Kangtai Biological Products、Sinovac Biotech、Janssen Pharmaceuticals、Crucell、Bavarian Nordic、Baxter、Bharat Biotech、Dynavax、Bausch Health、Protein Sciences、Panacea Biotec ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Preventable Vaccines Market
The global Preventable Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Preventable Vaccines Scope and Market Size
Preventable Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preventable Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Preventable Vaccines market is segmented into
Adult Preventable Vaccines
Pediatric Preventable Vaccines

Segment by Application, the Preventable Vaccines market is segmented into
Bacterial Diseases
Virus Diseases

Regional and Country-level Analysis
The Preventable Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Preventable Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Preventable Vaccines Market Share Analysis
Preventable Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Preventable Vaccines business, the date to enter into the Preventable Vaccines market, Preventable Vaccines product introduction, recent developments, etc.

The major vendors covered:
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec

レポート目次

---

1 Study Coverage
1.1 Preventable Vaccines Product Introduction
1.2 Market Segments
1.3 Key Preventable Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Preventable Vaccines Market Size Growth Rate by Type
1.4.2 Adult Preventable Vaccines
1.4.3 Pediatric Preventable Vaccines
1.5 Market by Application
1.5.1 Global Preventable Vaccines Market Size Growth Rate by Application
1.5.2 Bacterial Diseases
1.5.3 Virus Diseases
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Preventable Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Preventable Vaccines Revenue 2015-2026
2.1.2 Global Preventable Vaccines Sales 2015-2026
2.2 Global Preventable Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Preventable Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Preventable Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Preventable Vaccines Competitor Landscape by Players
3.1 Preventable Vaccines Sales by Manufacturers
3.1.1 Preventable Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Preventable Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Preventable Vaccines Revenue by Manufacturers
3.2.1 Preventable Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Preventable Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Preventable Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Preventable Vaccines Revenue in 2019
3.2.5 Global Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Preventable Vaccines Price by Manufacturers
3.4 Preventable Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Preventable Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Preventable Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Preventable Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Preventable Vaccines Market Size by Type (2015-2020)
4.1.1 Global Preventable Vaccines Sales by Type (2015-2020)
4.1.2 Global Preventable Vaccines Revenue by Type (2015-2020)
4.1.3 Preventable Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Preventable Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Preventable Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Preventable Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Preventable Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Preventable Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Preventable Vaccines Market Size by Application (2015-2020)
5.1.1 Global Preventable Vaccines Sales by Application (2015-2020)
5.1.2 Global Preventable Vaccines Revenue by Application (2015-2020)
5.1.3 Preventable Vaccines Price by Application (2015-2020)
5.2 Preventable Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Preventable Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Preventable Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Preventable Vaccines Price Forecast by Application (2021-2026)

6 North America
6.1 North America Preventable Vaccines by Country
6.1.1 North America Preventable Vaccines Sales by Country
6.1.2 North America Preventable Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Preventable Vaccines Market Facts & Figures by Type
6.3 North America Preventable Vaccines Market Facts & Figures by Application

7 Europe
7.1 Europe Preventable Vaccines by Country
7.1.1 Europe Preventable Vaccines Sales by Country
7.1.2 Europe Preventable Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Preventable Vaccines Market Facts & Figures by Type
7.3 Europe Preventable Vaccines Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Preventable Vaccines by Region
8.1.1 Asia Pacific Preventable Vaccines Sales by Region
8.1.2 Asia Pacific Preventable Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Preventable Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Preventable Vaccines Market Facts & Figures by Application

9 Latin America
9.1 Latin America Preventable Vaccines by Country
9.1.1 Latin America Preventable Vaccines Sales by Country
9.1.2 Latin America Preventable Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Preventable Vaccines Market Facts & Figures by Type
9.3 Central & South America Preventable Vaccines Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Preventable Vaccines by Country
10.1.1 Middle East and Africa Preventable Vaccines Sales by Country
10.1.2 Middle East and Africa Preventable Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Preventable Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Preventable Vaccines Market Facts & Figures by Application

11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Preventable Vaccines Products Offered
11.2.5 Merck Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Preventable Vaccines Products Offered
11.3.5 Novartis Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Preventable Vaccines Products Offered
11.4.5 Pfizer Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Preventable Vaccines Products Offered
11.5.5 Sanofi Related Developments
11.6 Takeda Pharmaceutical
11.6.1 Takeda Pharmaceutical Corporation Information
11.6.2 Takeda Pharmaceutical Description and Business Overview
11.6.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Takeda Pharmaceutical Preventable Vaccines Products Offered
11.6.5 Takeda Pharmaceutical Related Developments
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Description and Business Overview
11.7.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Abbott Preventable Vaccines Products Offered
11.7.5 Abbott Related Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Description and Business Overview
11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Roche Preventable Vaccines Products Offered
11.8.5 Roche Related Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Description and Business Overview
11.9.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.9.4 AstraZeneca Preventable Vaccines Products Offered
11.9.5 AstraZeneca Related Developments
11.10 Mitsubishi Tanabe Pharma
11.10.1 Mitsubishi Tanabe Pharma Corporation Information
11.10.2 Mitsubishi Tanabe Pharma Description and Business Overview
11.10.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Products Offered
11.10.5 Mitsubishi Tanabe Pharma Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.12 Serum Institute of India
11.12.1 Serum Institute of India Corporation Information
11.12.2 Serum Institute of India Description and Business Overview
11.12.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Serum Institute of India Products Offered
11.12.5 Serum Institute of India Related Developments
11.13 LG Life Sciences
11.13.1 LG Life Sciences Corporation Information
11.13.2 LG Life Sciences Description and Business Overview
11.13.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.13.4 LG Life Sciences Products Offered
11.13.5 LG Life Sciences Related Developments
11.14 S K Chemicals
11.14.1 S K Chemicals Corporation Information
11.14.2 S K Chemicals Description and Business Overview
11.14.3 S K Chemicals Sales, Revenue and Gross Margin (2015-2020)
11.14.4 S K Chemicals Products Offered
11.14.5 S K Chemicals Related Developments
11.15 Shenzhen Kangtai Biological Products
11.15.1 Shenzhen Kangtai Biological Products Corporation Information
11.15.2 Shenzhen Kangtai Biological Products Description and Business Overview
11.15.3 Shenzhen Kangtai Biological Products Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Shenzhen Kangtai Biological Products Products Offered
11.15.5 Shenzhen Kangtai Biological Products Related Developments
11.16 Sinovac Biotech
11.16.1 Sinovac Biotech Corporation Information
11.16.2 Sinovac Biotech Description and Business Overview
11.16.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Sinovac Biotech Products Offered
11.16.5 Sinovac Biotech Related Developments
11.17 Janssen Pharmaceuticals
11.17.1 Janssen Pharmaceuticals Corporation Information
11.17.2 Janssen Pharmaceuticals Description and Business Overview
11.17.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Janssen Pharmaceuticals Products Offered
11.17.5 Janssen Pharmaceuticals Related Developments
11.18 Crucell
11.18.1 Crucell Corporation Information
11.18.2 Crucell Description and Business Overview
11.18.3 Crucell Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Crucell Products Offered
11.18.5 Crucell Related Developments
11.19 Bavarian Nordic
11.19.1 Bavarian Nordic Corporation Information
11.19.2 Bavarian Nordic Description and Business Overview
11.19.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Bavarian Nordic Products Offered
11.19.5 Bavarian Nordic Related Developments
11.20 Baxter
11.20.1 Baxter Corporation Information
11.20.2 Baxter Description and Business Overview
11.20.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Baxter Products Offered
11.20.5 Baxter Related Developments
11.21 Bharat Biotech
11.21.1 Bharat Biotech Corporation Information
11.21.2 Bharat Biotech Description and Business Overview
11.21.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Bharat Biotech Products Offered
11.21.5 Bharat Biotech Related Developments
11.22 Dynavax
11.22.1 Dynavax Corporation Information
11.22.2 Dynavax Description and Business Overview
11.22.3 Dynavax Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Dynavax Products Offered
11.22.5 Dynavax Related Developments
11.23 Bausch Health
11.23.1 Bausch Health Corporation Information
11.23.2 Bausch Health Description and Business Overview
11.23.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.23.4 Bausch Health Products Offered
11.23.5 Bausch Health Related Developments
11.24 Protein Sciences
11.24.1 Protein Sciences Corporation Information
11.24.2 Protein Sciences Description and Business Overview
11.24.3 Protein Sciences Sales, Revenue and Gross Margin (2015-2020)
11.24.4 Protein Sciences Products Offered
11.24.5 Protein Sciences Related Developments
11.25 Panacea Biotec
11.25.1 Panacea Biotec Corporation Information
11.25.2 Panacea Biotec Description and Business Overview
11.25.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
11.25.4 Panacea Biotec Products Offered
11.25.5 Panacea Biotec Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Preventable Vaccines Market Estimates and Projections by Region
12.1.1 Global Preventable Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Preventable Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Preventable Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Preventable Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Preventable Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Preventable Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Preventable Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Preventable Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Preventable Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Preventable Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Preventable Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Preventable Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Preventable Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Preventable Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Preventable Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Preventable Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Preventable Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Preventable Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Preventable Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Preventable Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Preventable Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Preventable Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Preventable Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Preventable Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Preventable Vaccines Market Segments
Table 2. Ranking of Global Top Preventable Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Preventable Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Adult Preventable Vaccines
Table 5. Major Manufacturers of Pediatric Preventable Vaccines
Table 6. Global Preventable Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Preventable Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Preventable Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Preventable Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Preventable Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Preventable Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Preventable Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Preventable Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Preventable Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventable Vaccines as of 2019)
Table 15. Preventable Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Preventable Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Preventable Vaccines Price (2015-2020) (USD/Unit)
Table 18. Preventable Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Preventable Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Preventable Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Preventable Vaccines Sales by Type (2015-2020) (K Units)
Table 23. Global Preventable Vaccines Sales Share by Type (2015-2020)
Table 24. Global Preventable Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Preventable Vaccines Revenue Share by Type (2015-2020)
Table 26. Preventable Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Preventable Vaccines Sales by Application (2015-2020) (K Units)
Table 28. Global Preventable Vaccines Sales Share by Application (2015-2020)
Table 29. North America Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 30. North America Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Preventable Vaccines Sales by Type (2015-2020) (K Units)
Table 34. North America Preventable Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Preventable Vaccines Sales by Application (2015-2020) (K Units)
Table 36. North America Preventable Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 38. Europe Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Preventable Vaccines Sales by Type (2015-2020) (K Units)
Table 42. Europe Preventable Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Preventable Vaccines Sales by Application (2015-2020) (K Units)
Table 44. Europe Preventable Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Preventable Vaccines Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Preventable Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Preventable Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Preventable Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Preventable Vaccines Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Preventable Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Preventable Vaccines Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Preventable Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 54. Latin America Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Preventable Vaccines Sales by Type (2015-2020) (K Units)
Table 58. Latin America Preventable Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Preventable Vaccines Sales by Application (2015-2020) (K Units)
Table 60. Latin America Preventable Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Preventable Vaccines Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Preventable Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Preventable Vaccines Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Preventable Vaccines Sales Market Share by Application (2015-2020)
Table 69. GlaxoSmithKline Corporation Information
Table 70. GlaxoSmithKline Description and Major Businesses
Table 71. GlaxoSmithKline Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. GlaxoSmithKline Product
Table 73. GlaxoSmithKline Recent Development
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Major Businesses
Table 81. Novartis Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Novartis Product
Table 83. Novartis Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Sanofi Corporation Information
Table 90. Sanofi Description and Major Businesses
Table 91. Sanofi Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Sanofi Product
Table 93. Sanofi Recent Development
Table 94. Takeda Pharmaceutical Corporation Information
Table 95. Takeda Pharmaceutical Description and Major Businesses
Table 96. Takeda Pharmaceutical Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Takeda Pharmaceutical Product
Table 98. Takeda Pharmaceutical Recent Development
Table 99. Abbott Corporation Information
Table 100. Abbott Description and Major Businesses
Table 101. Abbott Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Abbott Product
Table 103. Abbott Recent Development
Table 104. Roche Corporation Information
Table 105. Roche Description and Major Businesses
Table 106. Roche Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Roche Product
Table 108. Roche Recent Development
Table 109. AstraZeneca Corporation Information
Table 110. AstraZeneca Description and Major Businesses
Table 111. AstraZeneca Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. AstraZeneca Product
Table 113. AstraZeneca Recent Development
Table 114. Mitsubishi Tanabe Pharma Corporation Information
Table 115. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 116. Mitsubishi Tanabe Pharma Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Mitsubishi Tanabe Pharma Product
Table 118. Mitsubishi Tanabe Pharma Recent Development
Table 119. Lupin Corporation Information
Table 120. Lupin Description and Major Businesses
Table 121. Lupin Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Lupin Product
Table 123. Lupin Recent Development
Table 124. Serum Institute of India Corporation Information
Table 125. Serum Institute of India Description and Major Businesses
Table 126. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Serum Institute of India Product
Table 128. Serum Institute of India Recent Development
Table 129. LG Life Sciences Corporation Information
Table 130. LG Life Sciences Description and Major Businesses
Table 131. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. LG Life Sciences Product
Table 133. LG Life Sciences Recent Development
Table 134. S K Chemicals Corporation Information
Table 135. S K Chemicals Description and Major Businesses
Table 136. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. S K Chemicals Product
Table 138. S K Chemicals Recent Development
Table 139. Shenzhen Kangtai Biological Products Corporation Information
Table 140. Shenzhen Kangtai Biological Products Description and Major Businesses
Table 141. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Shenzhen Kangtai Biological Products Product
Table 143. Shenzhen Kangtai Biological Products Recent Development
Table 144. Sinovac Biotech Corporation Information
Table 145. Sinovac Biotech Description and Major Businesses
Table 146. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Sinovac Biotech Product
Table 148. Sinovac Biotech Recent Development
Table 149. Janssen Pharmaceuticals Corporation Information
Table 150. Janssen Pharmaceuticals Description and Major Businesses
Table 151. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Janssen Pharmaceuticals Product
Table 153. Janssen Pharmaceuticals Recent Development
Table 154. Crucell Corporation Information
Table 155. Crucell Description and Major Businesses
Table 156. Crucell Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Crucell Product
Table 158. Crucell Recent Development
Table 159. Bavarian Nordic Corporation Information
Table 160. Bavarian Nordic Description and Major Businesses
Table 161. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Bavarian Nordic Product
Table 163. Bavarian Nordic Recent Development
Table 164. Baxter Corporation Information
Table 165. Baxter Description and Major Businesses
Table 166. Baxter Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 167. Baxter Product
Table 168. Baxter Recent Development
Table 169. Bharat Biotech Corporation Information
Table 170. Bharat Biotech Description and Major Businesses
Table 171. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 172. Bharat Biotech Product
Table 173. Bharat Biotech Recent Development
Table 174. Dynavax Corporation Information
Table 175. Dynavax Description and Major Businesses
Table 176. Dynavax Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 177. Dynavax Product
Table 178. Dynavax Recent Development
Table 179. Bausch Health Corporation Information
Table 180. Bausch Health Description and Major Businesses
Table 181. Bausch Health Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 182. Bausch Health Product
Table 183. Bausch Health Recent Development
Table 184. Protein Sciences Corporation Information
Table 185. Protein Sciences Description and Major Businesses
Table 186. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 187. Protein Sciences Product
Table 188. Protein Sciences Recent Development
Table 189. Panacea Biotec Corporation Information
Table 190. Panacea Biotec Description and Major Businesses
Table 191. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 192. Panacea Biotec Product
Table 193. Panacea Biotec Recent Development
Table 194. Global Preventable Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 195. Global Preventable Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 196. Global Preventable Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 197. Global Preventable Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 198. North America: Preventable Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 199. North America: Preventable Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 200. Europe: Preventable Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 201. Europe: Preventable Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 202. Asia Pacific: Preventable Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 203. Asia Pacific: Preventable Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 204. Latin America: Preventable Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 205. Latin America: Preventable Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 206. Middle East and Africa: Preventable Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 207. Middle East and Africa: Preventable Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 208. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 209. Key Challenges
Table 210. Market Risks
Table 211. Main Points Interviewed from Key Preventable Vaccines Players
Table 212. Preventable Vaccines Customers List
Table 213. Preventable Vaccines Distributors List
Table 214. Research Programs/Design for This Report
Table 215. Key Data Information from Secondary Sources
Table 216. Key Data Information from Primary Sources
List of Figures
Figure 1. Preventable Vaccines Product Picture
Figure 2. Global Preventable Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Adult Preventable Vaccines Product Picture
Figure 4. Pediatric Preventable Vaccines Product Picture
Figure 5. Global Preventable Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Bacterial Diseases
Figure 7. Virus Diseases
Figure 8. Preventable Vaccines Report Years Considered
Figure 9. Global Preventable Vaccines Market Size 2015-2026 (US$ Million)
Figure 10. Global Preventable Vaccines Sales 2015-2026 (K Units)
Figure 11. Global Preventable Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Preventable Vaccines Sales Market Share by Region (2015-2020)
Figure 13. Global Preventable Vaccines Sales Market Share by Region in 2019
Figure 14. Global Preventable Vaccines Revenue Market Share by Region (2015-2020)
Figure 15. Global Preventable Vaccines Revenue Market Share by Region in 2019
Figure 16. Global Preventable Vaccines Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Preventable Vaccines Revenue in 2019
Figure 18. Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Preventable Vaccines Sales Market Share by Type (2015-2020)
Figure 20. Global Preventable Vaccines Sales Market Share by Type in 2019
Figure 21. Global Preventable Vaccines Revenue Market Share by Type (2015-2020)
Figure 22. Global Preventable Vaccines Revenue Market Share by Type in 2019
Figure 23. Global Preventable Vaccines Market Share by Price Range (2015-2020)
Figure 24. Global Preventable Vaccines Sales Market Share by Application (2015-2020)
Figure 25. Global Preventable Vaccines Sales Market Share by Application in 2019
Figure 26. Global Preventable Vaccines Revenue Market Share by Application (2015-2020)
Figure 27. Global Preventable Vaccines Revenue Market Share by Application in 2019
Figure 28. North America Preventable Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Preventable Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Preventable Vaccines Sales Market Share by Country in 2019
Figure 31. North America Preventable Vaccines Revenue Market Share by Country in 2019
Figure 32. U.S. Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Preventable Vaccines Market Share by Type in 2019
Figure 37. North America Preventable Vaccines Market Share by Application in 2019
Figure 38. Europe Preventable Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Preventable Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Preventable Vaccines Sales Market Share by Country in 2019
Figure 41. Europe Preventable Vaccines Revenue Market Share by Country in 2019
Figure 42. Germany Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Preventable Vaccines Market Share by Type in 2019
Figure 53. Europe Preventable Vaccines Market Share by Application in 2019
Figure 54. Asia Pacific Preventable Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Preventable Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Preventable Vaccines Sales Market Share by Region in 2019
Figure 57. Asia Pacific Preventable Vaccines Revenue Market Share by Region in 2019
Figure 58. China Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Preventable Vaccines Market Share by Type in 2019
Figure 81. Asia Pacific Preventable Vaccines Market Share by Application in 2019
Figure 82. Latin America Preventable Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Preventable Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Preventable Vaccines Sales Market Share by Country in 2019
Figure 85. Latin America Preventable Vaccines Revenue Market Share by Country in 2019
Figure 86. Mexico Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Preventable Vaccines Market Share by Type in 2019
Figure 93. Latin America Preventable Vaccines Market Share by Application in 2019
Figure 94. Middle East and Africa Preventable Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Preventable Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Preventable Vaccines Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Preventable Vaccines Revenue Market Share by Country in 2019
Figure 98. Turkey Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Preventable Vaccines Market Share by Type in 2019
Figure 105. Middle East and Africa Preventable Vaccines Market Share by Application in 2019
Figure 106. North America Preventable Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Preventable Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Preventable Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Preventable Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Preventable Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Preventable Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Preventable Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Preventable Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Preventable Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Preventable Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed

---